Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Open Access Research article

Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial

Brinda Emu, Diana Luca, Carolyn Offutt, Jane L Grogan, Bernadette Rojkovich, Marna B Williams, Meina T Tang, Jim Xiao, June H Lee and John C Davis*

Arthritis Research & Therapy 2012, 14:R6  doi:10.1186/ar3554

Accesses  

  • Last 30 days: 97 accesses
  • Last 365 days: 1242 accesses
  • All time: 3652 accesses

Cited by